Echo Therapeutics, Inc. (ECTE.OB) Announces Clinical Study for New Glucose Monitoring Product

By Jonathan
05 November 2009 @ 04:36 am EDT

Echo Therapeutics, Inc., a diabetes management company developing a new needle-free Glocose Monitoring System, reports starting a new a clinical study of its Symphony(TM) Transdermal Continuous Glucose Monitoring product. The (tCGM System) study includes patients with Type 1 and Type 2 diabetes. The purpose of the study is to test the performance of its new one-piece, cost-effective biosensor. Echo expects to announce completed results of the study by the fourth quarter of 2009.

Small Cap News in collaboration with Quality Stocks

E-Newsletters

We value your privacy. Your email address will not be shared.